Biofrontera Inc.
BFRINASDAQHealthcare● Active
$0.93
$-0.01(-0.53%)
Market Cap$11907110
P/E Ratio—
52W High$1.19
52W Low$0.555
Biofrontera Inc. (BFRI) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BFRI · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $41.70M | $37.30M | $34.07M | $28.67M | $24.10M |
| Cost of Revenue | $8.90M | $18.61M | $17.44M | $15.19M | $12.74M |
| Gross Profit | $32.80M | $18.70M | $16.63M | $13.49M | $11.36M |
| Gross Margin %(computed) | 78.65% | 50.12% | 48.80% | 47.04% | 47.13% |
| Operating Expenses | |||||
| R&D Expenses | $3.72M | $2.09M | $0.08M | $0.00M | $0.00M |
| G&A Expenses | $0.00M | $0.00M | $37.70M | $35.87M | $37.21M |
| Total Operating Expenses | $41.95M | $35.92M | $39.30M | $32.07M | $36.56M |
| Operating Income | ($9.15M) | ($17.21M) | ($22.68M) | ($18.58M) | ($25.20M) |
| Operating Margin %(computed) | -21.94% | -46.14% | -66.56% | -64.80% | -104.57% |
| Interest Income | $0.00M | $0.03M | $0.13M | $0.17M | $0.02M |
| Interest Expense | $0.45M | $2.11M | $0.60M | $0.37M | $0.36M |
| Income Before Tax | ($10.51M) | ($17.74M) | ($20.12M) | ($0.61M) | ($37.66M) |
| Income Tax Expense | $0.03M | $0.02M | $0.01M | $0.03M | $0.06M |
| Net Income | ($10.54M) | ($17.76M) | ($20.13M) | ($0.64M) | ($37.71M) |
| Net Margin %(computed) | -25.26% | -47.61% | -59.09% | -2.23% | -156.49% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-1.04 | $-3.22 | $-13.02 | $-0.61 | $-44.10 |
| Wtd Avg Shares | 10.17M | 5.52M | 1.55M | 1.06M | 0.86M |
| EBITDA | ($8.28M) | ($14.44M) | ($18.45M) | $0.93M | ($36.76M) |
| EBITDA Margin %(computed) | -19.85% | -38.71% | -54.16% | 3.26% | -152.52% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · M
Explore more Biofrontera Inc. data
About Biofrontera Inc. (BFRI) Income Statement
Biofrontera Inc. (BFRI) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, BFRI reported revenue of $0.04B, gross profit of $0.03B (gross margin 78.65%), and net income of ($0.01B) — a net profit margin of -25.26%.
Frequently asked questions
BFRI · 4 questionsBiofrontera Inc. (BFRI) reported revenue of $0.04B for 2025, up 11.8% year-over-year.
BFRI revenueBFRI salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08